Related Experiment Video

Updated: Jun 17, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
23:33

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

What is the appropriate approach to prevention of thromboembolism in heart failure?

Ronald S Freudenberger1, Matthew M Schumaecker, Shunichi Homma

  • 1Center for Advanced Heart Failure Lehigh Valley Health Network Penn State College of Medicine Allentown, PA, USA. ron.freudenberger@gmail.com

Thrombosis and Haemostasis
|December 22, 2009
PubMed

Insights

Anticoagulants are sometimes used for primary prevention in heart failure (HF) patients, but evidence is lacking. Ongoing trials like WARCEF aim to clarify their routine use in HF management.

Area of Science:

  • Cardiology
  • Thromboembolic disease
  • Heart Failure research

Background:

  • Heart failure (HF), especially with left ventricular systolic dysfunction, is linked to increased thromboembolic events like stroke and pulmonary embolism.
  • Some clinicians use anticoagulants for primary prevention in HF patients, despite limited supporting data.
  • Existing research, including retrospective analyses and underpowered randomized trials, provides conflicting results on anticoagulant efficacy in HF.

Purpose of the Study:

  • To evaluate the current evidence regarding the use of anticoagulants for primary prevention of thromboembolic events in patients with heart failure.
  • To highlight the lack of consensus among professional societies on anticoagulant recommendations for HF.
  • To emphasize the need for robust clinical trial data, such as from WARCEF, to guide clinical practice.

Main Methods:

  • Review of existing literature, including retrospective analyses of large heart failure trials.
  • Analysis of the limitations of previous randomized controlled trials addressing anticoagulation in HF.
  • Anticipation of results from ongoing clinical trials, specifically WARCEF.

Main Results:

  • Contradictory findings from retrospective analyses of heart failure trials.
  • Under-population and insufficient power in previous randomized trials designed to assess anticoagulants in HF.
  • Absence of a general consensus among professional societies regarding anticoagulant use in HF patients.

Conclusions:

  • The routine use of anticoagulants for primary prevention in heart failure is not currently supported by robust scientific data.
  • There is a significant need for well-powered clinical trials to establish evidence-based guidelines for anticoagulant therapy in HF.
  • Results from ongoing trials like WARCEF are expected to provide crucial insights for clinicians.

Related Concept Videos

Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Pulmonary Embolism III: Nursing Management01:27

Pulmonary Embolism III: Nursing Management

A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...